Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

ClinicalTrials.gov ID: NCT00975221

Public ClinicalTrials.gov record NCT00975221. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinacalcet for the Treatment of Hypercalcemia in Subjects With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to demonstrate the efficacy and to assess the safety of cinacalcet for the reduction of hypercalcemia in patients with primary hyperparathyroidism for whom parathyroidectomy is indicated on the basis of an elevated corrected total serum calcium, but who are unable to undergo parathyroidectomy.

Study identification

NCT ID
NCT00975221
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
67 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 10, 2010 (Actual)
Primary completion
Jul 12, 2012 (Actual)
Completion
Dec 21, 2012 (Actual)
Last update posted
Oct 17, 2018

2010 – 2012

United States locations

U.S. sites
22
U.S. states
11
U.S. cities
22
Facility City State ZIP Site status
Research Site Lake Forest California 92630 —
Research Site Lancaster California 93534 —
Research Site Los Gatos California 95032 —
Research Site Mission Viejo California 92691 —
Research Site Orange California 92869 —
Research Site San Diego California 92124 —
Research Site Aurora Colorado 80045 —
Research Site Washington D.C. District of Columbia 20010 —
Research Site Aventura Florida 33180 —
Research Site Clearwater Florida 33756 —
Research Site Jacksonville Florida 32204 —
Research Site Miami Florida 33145 —
Research Site Pembroke Pines Florida 33028 —
Research Site Weston Florida 33331 —
Research Site Atlanta Georgia 30322 —
Research Site Indianapolis Indiana 46202 —
Research Site Kenner Louisiana 70065 —
Research Site New Orleans Louisiana 70121 —
Research Site Detroit Michigan 48236 —
Research Site New York New York 10032 —
Research Site Morehead City North Carolina 28557 —
Research Site Columbus Ohio 43210-1296 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00975221, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 17, 2018 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00975221 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →